Filing summary
Registrant and period: The supplied filing is ASGN Incorporated’s unaudited Form 10-Q for the quarter and nine months ended September 30, 2023. This differs from the request metadata naming Everforth Inc.; the filing identifies ASGN Incorporated as the registrant.
Business context
ASGN provides IT services and professional solutions through Commercial and Federal Government segments. Virtually all revenue is generated in the United States. The Commercial segment serves primarily large enterprises; the Federal Government segment serves defense, intelligence, and civilian agencies.
Financial performance
| Metric | Q3 2023 | Q3 2022 | Nine months 2023 | Nine months 2022 |
|---|---|---|---|---|
| Revenue | $1,116.8 million | $1,197.9 million | $3,376.5 million | $3,430.7 million |
| Gross profit / margin | $322.4 million / 28.9% | $358.9 million / 30.0% | $975.1 million / 28.9% | $1,029.5 million / 30.0% |
| Operating income | $98.6 million | $108.4 million | $280.7 million | $319.1 million |
| Net income | $59.4 million | $73.2 million | $169.0 million | $212.5 million |
| Diluted EPS | $1.23 | $1.44 | $3.43 | $4.11 |
| Interest expense | $18.5 million | $12.1 million | $49.7 million | $31.5 million |
- Q3 revenue declined 6.8% year over year; Commercial revenue fell 13.1%, including a 19.5% drop in assignment revenue, while Federal Government revenue grew 12.3%. Commercial consulting revenue rose 2.1%.
- For the first nine months, revenue declined 1.6%; excluding approximately $128.0 million from businesses acquired in the prior 12 months, revenue declined 5.3%. Assignment revenue fell 15.3%, while IT consulting services revenue increased 15.2%.
- Gross margin contracted 110 basis points in both the quarter and nine-month comparison. Management attributed the decline mainly to a lower mix of certain higher-margin Commercial assignment services and a greater contribution from the lower-margin Federal Government segment.
- SG&A was $206.0 million in Q3 and $640.6 million year to date, down from comparable prior-year amounts; lower incentive compensation was the primary reason. Higher interest rates increased interest expense; Q3 also included $2.3 million of credit-facility amendment costs.
Cash flow, balance sheet, and debt
- Nine-month operating cash flow was $340.5 million, versus $232.5 million in 2022. Capital expenditures were $32.7 million; investing cash outflow was $33.3 million. Financing cash outflow was $231.6 million, including $197.7 million of share repurchases.
- Cash was $145.6 million at September 30, 2023, compared with $70.3 million at December 31, 2022. Working capital was $550.7 million. Accounts receivable was $804.6 million, down from $853.6 million at year-end.
- Long-term debt on the balance sheet was $1,037.5 million, compared with $1,066.6 million at year-end. The company reported full availability under its $500 million revolver and compliance with debt covenants. It stated cash, expected operating cash flow, and revolver availability should cover obligations, working capital, and capital expenditures for the next 12 months.
- An August 2023 facility amendment extended term-loan maturity to August 2030 and revolver maturity to February 2028, increased revolver capacity to $500 million, and established annual minimum term-loan principal payments of $5 million. The company reported a 0.95-to-1 senior secured leverage ratio against a 3.75-to-1 covenant threshold when revolver borrowings are drawn. The $550 million senior notes mature in 2028 and bear 4.625% interest.
Outlook, risks, and unusual items
- No specific revenue or earnings guidance is provided. Management’s liquidity statement covers the next 12 months, but is not quantified as earnings guidance.
- Management described continued softness in more discretionary and cyclical Commercial business, particularly assignment services. Commercial consulting bookings were $291.0 million in Q3, with a 1.1-to-1 book-to-bill ratio; the comparable ratio was 0.9-to-1. Federal trailing-twelve-month new awards were $1,080.8 million, with a 0.9-to-1 book-to-bill ratio. Contract backlog was $3,278.8 million, including $701.0 million funded.
- Risks include short-notice termination rights on many Commercial consulting contracts, variability in federal contract awards and funding, and exposure to variable interest rates. The filing estimates a 100-basis-point rate change would change annual interest expense by approximately $5.0 million based on $500 million of variable-rate debt.
- The company reported ordinary-course litigation, including wage-and-hour class and PAGA actions, but did not expect pending matters to materially affect its financial position, results, or cash flows. It reported no material changes to previously disclosed risk factors and no fair-value adjustments for nonfinancial assets or liabilities during the nine months.
- A $500 million share-repurchase program was approved in April 2023. The company repurchased 1.15 million shares in Q3 for an average $79.76 per share; $349.1 million remained available under the program at quarter-end.
Key facts for investors to verify
- Confirm the registrant identity: the filing is for ASGN Incorporated, not Everforth Inc.
- Track whether Commercial assignment demand and revenue declines stabilize, and whether consulting growth offsets that weakness.
- Assess segment mix and gross-margin recovery, alongside the effects of higher interest rates and debt costs.
- Monitor federal contract awards, funded backlog conversion, and government funding or renewal timing.
- Review the pace of buybacks, remaining repurchase authorization, and debt repayment against cash generation and capital needs.